Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 EUR | +0.53% | +2.70% | -15.93% |
Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 53.48M 57.83M | Sales 2023 | 59.39M 64.22M | Capitalization | 51.4M 55.58M |
---|---|---|---|---|---|
Net income 2022 | 5M 5.41M | Net income 2023 | 5M 5.41M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 5.64M 6.1M | Net Debt 2023 | 7.26M 7.85M | EV / Sales 2023 | 0.99 x |
P/E ratio 2022 |
7.2
x | P/E ratio 2023 |
9.2
x | Employees | 79 |
Yield 2022 |
4.69% | Yield 2023 |
-
| Free-Float | 12.01% |
1 day | +0.53% | ||
1 week | +2.70% | ||
Current month | +0.53% | ||
1 month | +4.40% | ||
3 months | -3.55% | ||
6 months | -16.67% | ||
Current year | -15.93% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.8 | +0.53% | 2,750 |
24-05-22 | 3.78 | +2.72% | 15,500 |
24-05-21 | 3.68 | 0.00% | 0 |
24-05-20 | 3.68 | -1.08% | 750 |
24-05-17 | 3.72 | +0.54% | 750 |
Real-time Borsa Italiana, May 23, 2024 at 11:44 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.93% | 46.54M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- SHE Stock